top of page
Akthelia News Desk
Nov 13, 2024
Akthelia Pharmaceuticals featured in Icelandic newspaper Viðskiptablaðið
Akthelia Pharmaceuticals is featured in today's edition of the leading Icelandic business newspaper Viðskiptablaðið.
Akthelia News Desk
Oct 17, 2024
Akthelia Pharmaceuticals Awarded RANNIS Grant to Accelerate Development of Gastrimod® (AKT-011) for Chemotherapy-Induced FN
Akthelia Pharmaceuticals is pleased to announce it has been awarded a two-year $350,000 research grant by RANNIS
Akthelia News Desk
Sep 8, 2024
Akthelia Pharmaceuticals presents new translational mucosal barrier injury efficacy data at NLSD 2024
Akthelia Pharma will present exciting new translational data, and partnering and capital raising objectives at Nordic Life Science Days 2024
Akthelia News Desk
Apr 6, 2024
Akthelia receives European Commission Seal of Excellence
Akthelia Pharmaceuticals announce its award of the European Commission Seal of Excellence, a quality recognition by the European Union.
Akthelia News Desk
Apr 5, 2024
Meet Akthelia Pharmaceuticals at the LSX World Congress 2024
Akthelia Pharmaceuticals is at a pivotal juncture, with a strongly validated and developable lead asset, ready to enter IND-enabling studies
bottom of page